baber/WOPTO huggingface dataset:
Patent NZ-547024-A (NZ)
Title: Methods for the production of apolipoproteins in transgenic plants
Inventor: MOLONEY MAURICE M
IPC: A01H1/00
Filed: 2004-11-15
Abstract: Provided is a method for the expression of apolipoprotein in plants comprising: (a) providing a chimeric nucleic acid construct comprising in the 5' to 3' direction of transcription as operably linked components: (i) a nucleic acid sequence capable of controlling expression in plant cells; and (ii) a nucleic acid sequence encoding an apolipoprotein polypeptide; and (iii) a nucleic acid sequence that encodes either (1) a targeting signal capable of targeting the apolipoprotein to the endoplasmic reticulum or an endoplasmic reticulum derived storage vesicle or (2) a nucleic acid sequence encoding a signal peptide which is capable of targeting the apolipoprotein polypeptide to the apoplast and a stabilizing polypeptide, (b) introducing the chimeric nucleic acid construct into a plant cell; and (c) growing the plant cell into a mature plant wherein the plant expresses apolipoprotein. Further provided are corresponding expression vectors, transgenic plants and pure oil body compositions produced by such plants.
Patent NZ-548092-A (NZ)
Title: Method for producing a 2-(ethoxymethyl)tropane derivative
Inventor: EHLENZ RICHARD
IPC: C07D451/02
Filed: 2005-01-20
Abstract: Process for preparing a 2-(ethoxymethyI)-tropane derivative of formula (1) or a pharmaceutically acceptable salt thereof, wherein: R1 denotes hydrogen or C1-6 alkyl; and R2 denotes phenyl optionally mono- or polysubstituted by halogen, trifluoromethyl or cyano; characterised in that a 2-(hydroxymethyl)-tropane derivative of formula (II), wherein R1 and R2 are defined as for formula (I), is reacted with ethyl bromide in the presence of a base, a phase transfer catalyst, and optionally a diluent, and then optionally treated with an acid, and wherein the base is selected from the group consisting of lithium hydroxide, sodium hydroxide and potassium hydroxide.
Patent NZ-551400-A (NZ)
Title: Pelvic floor exercise device
Inventor: ARMITAGE CAROL
Filed: 2006-11-20
Abstract: A device for supporting or exercising the pelvic floor muscles in a female human is disclosed. The device has a generally sinuous unitary elongate body with a first enlarged end (3), a second enlarged end (5), and a relatively narrow interconnecting region (7). The first enlarged end (3), the second enlarged end (5), and the narrow interconnecting region (7) are insertable into the vagina to provide resistance to contraction of the pelvic floor muscles.
Patent NZ-563539-A (NZ)
Title: Sclerostin binding agents
Inventor: PASZTY CHRISTOPHER
IPC: C07K14/51
Filed: 2006-04-28
Abstract: Provided is an antibody or functional fragment thereof that cross-blocks or is cross-blocked from binding of at least one of antibodies Ab-A, Ab-1, Ab-4, Ab-5, Ab-19, Ab-20, and Ab-23 to sclerostin. The antibodies are useful for treating bone-related disorders in mammals.
Patent NZ-567537-A (NZ)
Title: A deburring device for gear
Inventor: XU XIAOHUA
IPC: B23F19/00
Filed: 2006-10-19
Abstract: A device for deburring gears comprising a horizontal, disc shaped supporting plate 3 which is supported on a base 23 by a spindle 20, with a rigid brush driven by a driving mechanism 12 set besides it. Some positioning components of the work-piece are provided on the upper surface of the plate and around its center. The driving mechanism 12 is fixed to a supporting board 11 that is in turn connected through an adjustable bolt to a supporting board 15, which is rotatably mounted on an adjustable base plate 16.
Patent NZ-570216-A (NZ)
Title: Functionalised nanoparticles, their production and use
Inventor: BALDI GIOVANNI
IPC: C07F9/38
Filed: 2007-01-03
Abstract: Disclosed are stable complexes composed of metal oxides, iron, cobalt or their alloys in nanoparticles form and difunctional compounds chosen from the group consisting of thiols, carboxylic acids, hydroxamic acids, phosphoric acid ester or salts thereof.
Patent NZ-572871-A (NZ)
Title: A sun shade or barrier that rolls up when not in use stored at the periphery of the shaded area
Inventor: DRIEL GRANT VAN
IPC: E04F10/06
Filed: 2008-11-14
Abstract: A barrier device (1) that stores a flexible barrier (2) wrapped around a shaft (3) is disclosed. The barrier (2) may be unwound to cover an area with only the barrier (2) inside that area. The device (1) consists of the barrier which is formed from sheet material, at least one anchor point (9c), a storage device for storing the barrier (2), and a line (6). The storage device includes the shaft (3) around which the barrier (2) is wrapped when in a stored position. The storage device is also positioned substantially outside the area the barrier (2) occupies while in an operational or un-stored position. A driving mechanism (4) is attached to the shaft (3) of the storage device which causes the shaft (3) to rotate, transferring the barrier (2) between the stored position and the operational position. The line (6) is attached between an attachment point (7c), on the opposite side of the barrier (2) to the shaft (3), and the driving mechanism (4) via an anchor point (9c). A biasing device (8) is mounted to the anchor point (9) and maintains the line (6) in a tensioned state. The biasing device (8) includes at least one pulley (10) through which the line (6) passes, and a spring (11) configured to bias the at least one pulley (10). The spring (11) is positioned substantially outside the area the barrier (2) occupies while in an operational position.
Patent NZ-573107-A (NZ)
Title: Hair coloring composition
Inventor: AZIZOVA MARINA
IPC: A61Q5/10
Filed: 2007-05-17
Abstract: A composition for colouring keratinaceous fibers with a vivid red color is disclosed, which comprising a combination of 2,4,5,6-tetraaminopyrimidine sulfate and 2,6-bis(2-hydroxyethylamino)toluene; wherein 2,4,5,6-tetraaminopyrimidine sulfate and 2,6-bis(2-hydroxyethylamino)toluene are the only hair dye ingredients in the composition. A method for colouring keratin fibers or hair is also disclosed comprising the steps of: (A) mixing 2,4,5,6-tetraaminopyrimidine sulfate and 2,6-bis(2-hydroxyethylamino)toluene in a hair application carrier to produce a hair dyeing composition; wherein 2,4,5,6-tetraaminopyrimidine sulfate and 2,6-bis(2-hydroxyethylamino)toluene are the only hair dye ingredients in the hair dyeing composition, (B) adding hydrogen peroxide to the hair dyeing composition as an oxidizing agent, and (C) applying the fully intermixed composition to hair fibers for producing a vibrant red color thereto. The method may further include the steps of: (D) mixing the individual constituents together at a temperature ranging between about 75 and 80 Deg. C; (E) allowing the composition to cool; and (F) adjusting the pH to between about 9.5 and 10 using NH4OH; (G) applying the hair dyeing composition to the hair fibers for 35 minutes at a temperature of 25 Deg. C; (H) rinsing the dyeing composition from the hair fibers; (I) washing the treated hair with a shampoo; and (J) drying the dye hair fibers.
Patent NZ-573452-A (NZ)
Title: Compositions and methods relating to novel compounds and targets thereof
Inventor: GLICK GARY D
IPC: A01N43/62
Filed: 2007-06-08
Abstract: Disclosed is a phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one represented by formula (I) including salts and both Rand S enantiomeric forms and racemic mixtures thereof wherein A1 is H, Br, Cl, nitro, or trifluoromethyl; R is methyl or H, R2 is defined in the specification, R3 is H, Br, Cl, nitro, or trifluromethyl; R5 is alkyl, phenyl, phenoxy, hydroxyphenyl, Br, F or CI; R6 is H, Br, CI, F, -methoxy, or ethoxy; X is NH for treating an immune disorder, a hyperproliferative disorder, and a chronic inflammatory condition, a graft versus host disease, rheumatoid arthritis, and systemic lupus erythematosusm, cancer, neoplasm, lymphoma, myeloma or leukemia, asthma and psoriasis.
Patent NZ-574173-A (NZ)
Title: Methods and compositions for the treatment and prevention of infections
Inventor: GILBARD JEFFREY P
IPC: A61K9/00
Filed: 2007-07-20
Abstract: Disclosed is an ophthalmologic preparation comprising chlorine dioxide as an oxidizing antibacterial agent and a xanthine as a heterocyclic compound wherein the heterocyclic compound improves the antibacterial effect of the oxidizing agent. The preparation is used for treating a microbial colonization or infection of the ocular surface or eyelid.
Patent NZ-575511-A (NZ)
Title: Processes for the preparation of 1,2,4-oxadiazole benzoic acids
Inventor: ALMSTEAD NEIL G
IPC: C07D271/06
Filed: 2007-09-06
Abstract: Disclosed is a process for preparing a compound of formula (I) wherein the variables are as disclosed in the specification and includes the steps of reacting the cyanobenzoic acid ester with hydroxylamine followed by acylation with a halobenzoyl chloride and condensation where the process is carried out in the same solvent. Also disclosed is the process for preparing a 1 ,2,4-oxadiazole benzoic acid or a pharmaceutically acceptable salt thereof comprising the steps of: (1) reacting a cyanobenzoic acid methyl ester with hydroxylamine; (2) acylation with a halo benzoyl chloride; (3) condensation; and (4) hydrolysis of the methyl ester, wherein each reaction step is carried out in the same organic solvent.
Patent NZ-576568-A (NZ)
Title: Method of improving salmon meat color with carotenoids
Inventor: HIRASAWA KAZUAKI
IPC: A23L17/00
Filed: 2007-09-14
Abstract: A method for producing a salmon having a mild reddish orange flesh colour that comprises cultivating the salmon with a feed comprising astaxanthin, phoenicoxanthin, canthaxanthin and adonixanthin. The content of astaxanthin in the feed is 20 to 100 mg/kg, and the content of phoenicoxanthin is 5 to 80 mg/kg. The fish produced by the method has phoenicoxanthin and astaxanthin in the flesh of the fish at a ratio of 5 to 80 percent (content of phoenicoxanthin in respect of astaxanthin).
Patent NZ-577694-A (NZ)
Title: Methods and systems for access control using a networked turnstele
Inventor: DENKER DENNIS
IPC: G07C9/02
Filed: 2007-12-06
Abstract: A method of controlling venue access and a computer controlled turnstile system are disclosed. The turnstile system comprises a turnstile, including a computer interface; and a computer system coupled to the turnstile and to user terminals. The computer system includes program code configured to receive an order from a user for a plurality of admissions to an event; associate the plurality of admissions with a single first ticket; provide a user interface via which the user can re-associate a first quantity of the plurality of admissions with a second ticket; store in memory information related to the re-association; at least partly in response to information obtained from the second ticket at a venue associated with the event, access the information and enable the turnstile to admit a number of persons that corresponds to the first quantity. The order is received from a user terminal; Also disclosed is a networked access control system comprising a network interface configured to receive user communications over a network and to receive ticket data read from tickets via a ticket reader located at an event venue; and program code stored in a computer readable medium, configured to receive a request for a first plurality of admissions for an event from a user; cause, at least in part, a user interface to be presented via which the user can associate a second plurality of admissions, which is a first subset of the first plurality of admissions, with a first ticket, and a second subset of the first plurality of admissions with a second ticket; store a definition of the first subset and the second subset received from the user; receive data from a ticket reader corresponding to the first ticket; use the first ticket data read from the first ticket to determine how many admissions are associated with the first ticket; and at least in part enable a number of people that correspond to the determination as how many admissions are associated with the first ticket to gain admission to the event.
Patent NZ-583069-A (NZ)
Title: Treatments using vitamin k analogues and derivatives
Inventor: VAIDYA RAMA A
IPC: C07C50/12
Filed: 2008-07-21
Abstract: Disclosed are therapeutic uses of vitamin K, its analogues and derivatives in a diverse array of disease conditions. Vitamin K improves blood perfusion and ameliorates hypoxia in prevention and treatment of conditions such as chronic venous insufficiency manifestations, post thrombotic syndrome, skin conditions related to melanization, hyperpigmentation, Paresthesiae, oedema, varicose veins, VTE and cramps. The invention also provides pharmaceutical compositions comprising vitamin K, its analogues, derivatives or vitamin K-like compounds either alone or in combination with one or more therapeutically effective active agents for the diseases/conditions of venous, nerves and lymph, that are encompassed by this invention.
Patent NZ-583712-A (NZ)
Title: Compositions for sealing wounds in woody plants
Inventor: STADLER REINHOLD
IPC: A01N25/10
Filed: 2008-09-23
Abstract: Disclosed is a liquid composition comprising a) a water-insoluble sealing material in dissolved or dispersed form, which is selected from among water-insoluble film-forming polymers and waxes and their mixtures, in an amount of 1 to 40 percent by weight, based on the total weight of the composition; b) at least one plant protectant e.g. strobulins; c) at least one volatile diluent, wherein the diluent comprises at least 70 percent by weight of water, based on the total amount of diluent; and d) at least one nonionic surface-active substance in an amount of from 10 to 100 percent by weight, based on the sealing material.
Patent NZ-588388-A (NZ)
Title: Carboline derivatives useful in the inhibition of angiogenesis
Inventor: MOON YOUNG-CHOON
IPC: A61K31/437
Filed: 2005-03-15
Abstract: Carboline compounds of formula (IV) that inhibit the expression of VEGF post-transcriptionally, and methods for their use have been disclosed, wherein the variables are as defined in the specification. These compounds are useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration.
Patent NZ-593002-A (NZ)
Title: Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
Inventor: ZOU NING
IPC: A61K31/415
Filed: 2009-11-24
Abstract: Abstract 593002 The disclosure relates to Pyrazole substituted carbonic acid derivatives derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor Disclosed are Compounds and pharmaceutical compositions thereof useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders such as: platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). The disclosed compounds include: 2-(((1s,4s)-4-((4-(3-chlorophenyl)-5-methyl-3-phenyl-1H-pyrazol-1-yl)methyl)cyclohexyl)methoxy)acetic acid; 2-(((1s,4s)-4-((4-(2-chlorophenyl)-5-methyl-3-phenyl-1H-pyrazol-1-yl)methyl)cyclohexyl)methoxy)acetic acid 2-(((1s,4s)-4-((4-(3-fluorophenyl)-5-(methylthio)-3-phenyl-1H-pyrazol-1-yl)methyl)cyclohexyl)methoxy)acetic acid 2-(((1r,4r)-4-((3-(2-amino-2-oxoethoxy)-4-(2-fluoro-3-methoxyphenyl)-5-phenyl-1H-pyrazol-1-yl)methyl)cyclohexyl)methoxy)acetic acid And 2-(((1s,4s)-4-((1-p-tolyl-4,5-dihydro-3H-benzo[e]indazol-3-yl)methyl)cyclohexyl)methoxy)acetic acid
Patent NZ-596746-A (NZ)
Title: Blood-derived supplement with platelets activator for cell cultivation media
Inventor: LIN YUNG-KAI
IPC: C12N5/071
Filed: 2011-11-29
Abstract: Provided is a method for making a supplement for cell cultivation media, comprising: (a) centrifuging mammal blood and collecting supernatant; (b) adding platelets activator into the supernatant to obtain activation supernatant; and (c) sterilizing the activation supernatant, wherein platelets activator contains collagen, thrombin and CaCl2, and wherein concentrations of the collagen, thrombin and CaCl2 are in a range selected from the group consisting of: collagen has concentration from 1000 ug/ml to 5000 ug/ml, thrombin has concentration from 5 U/ml to 50 U/ml, and CaCl2 has concentration from 0.1 % to 4.0 %; collagen has concentration from 1000 ug/ml to 5000 ug/ml, thrombin has concentration from 0.1 U/ml to 2.0 U/ml, and CaCl2 has concentration from 0.1 % to 4.0 %; and collagen has concentration from 10 ug/ml to 800 ug/ml, thrombin has concentration from 5 U/ml to 50 U/ml, and CaCl2 has concentration from 0.1 % to 4.0 %.
Patent NZ-600864-A (NZ)
Title: Fumigant/sterilant
Inventor: RYAN ROBERT FRANCIS
IPC: A23B9/22
Filed: 2004-10-15
Abstract: ABSTRACT - 600864 The disclosure relates to use of a mixture of cyanogen in an amount of more than 6.6% v/v and less than or equal to 26% v/v and carbon dioxide to create a sufficiently oxygen-deficient environment such that when said mixture of cyanogen and carbon dioxide is added to air, said cyanogen remains below its flammability limit, wherein the amount of carbon dioxide present is 93 to 74 wt %, and wherein said cyanogen is in the form of a liquefied gas and said carbon dioxide is liquid or gaseous form. This fumigant/sterilant mixture of cyanogen and carbon dioxide is suitable for fumigating and/or sterilising soil or commodities such as timber in enclosed spaces with reduced health and safety risk.
Patent NZ-604060-A (NZ)
Title: Pesticidal (hetero) arylpyrrolidines
Inventor: GORGENS ULRICH
IPC: A01N43/36
Filed: 2009-10-05
Abstract: 604060 Disclosed are arylpyrrolidines compounds which exhibit excellent insecticidal efficacy and which may be used as in the agrochemical field or in the field of veterinary medicine. The compounds are represented by formula (I): wherein the respective substituents are defined in the specification. Where G is CONR1R2 or CSNR1R2 and the other substituents are as disclosed in the specification. Compounds of Formula (I) are useful as pesticides in agriculture or as a pharmaceutical for treating parasites in or on animals.
Patent NZ-606129-A (NZ)
Title: Process for producing a biocrude employing microalgae
Inventor: STROÏAZZO-MOUGIN BERNARD A J
IPC: C12P7/64
Filed: 2010-06-23
Abstract: Disclosed is a procedure for obtaining a biocrude from a gas comprising CO2, procedure which comprises the steps of: a) supply of the gas which comprises CO2 to a reactor containing 5 a culture which comprises at least one species of microalga which is capable of photosynthesis; b) photosynthesis carried out by the species of microalga using the CO2 supplied to produce a biomass; c) anaerobic fermentation of the biomass obtained; d) thermochemical decomposition of the biomass fermented at a pressure between 0 and 20 MPa and a temperature between 200 and 420ºC in order to obtain a biocrude mixed with water and gases, and e) separation of the biocrude obtained, wherein following the photosynthesis stage, between 5 and 100% of the culture is removed from the reactor which is subsequently separated into a solid fraction which contains biomass, which solid fraction will subsequently be subjected to the stage of anaerobic fermentation, and a liquid fraction containing carbonates and/or bicarbonates, which are separated from the liquid fraction, and which liquid fraction is returned at least partially to the reactor substantially devoid of carbonates and bicarbonates.
Patent NZ-609389-A (NZ)
Title: Recombinant flavivirus vaccines
Inventor: PUGACHEV KONSTANTIN V
IPC: C12P21/06
Filed: 2006-04-24
Abstract: Disclosed is a chimeric flavivirus comprising a yellow fever virus of strain YF17D in which the membrane and envelope proteins of the yellow fever virus are replaced with the membrane and envelope proteins of West Nile virus strain NY99, wherein said chimeric flavivirus comprises the following mutations: (a) the substitutions L107F, A316V and K440R in the envelope protein; (b) the C2 deletion (deletion of amino acids PSR, residues 40-42) in the capsid protein; and additionally either: (c)(i) a deletion in the 3’ untranslated region (3’ UTR) of the chimeric flavivirus genome selected from: dB (deletion of CAGGT, nucleotides 256-260), dD (deletion of CGGAG, nucleotides 308-312) and d7 (deletion of AAGACGG, nucleotides 345-351); or (c)(ii) the substitutions Y176V, T177A and K280M in the envelope protein.
Patent NZ-611799-A (NZ)
Title: Cellulosic and lignocellulosic structural materials and methods and systems for manufacturing such materials by irradiation
Inventor: MEDOFF MARSHALL
IPC: B05D3/00
Filed: 2009-04-28
Abstract: Disclosed is a method of treating wood, the method comprising irradiating wood that has been injected with a lignin comprising liquid, to give wood comprising cross-linked lignin. Additionally disclosed is where wood fibre is treated by irradiating wood fibre to which lignin has been added.
Patent NZ-613256-A (NZ)
Title: Porous block nanofiber composite filters
Inventor: MIEDANER ALEXANDER
IPC: B01D46/00
Filed: 2008-11-21
Abstract: Disclosed is a porous block nano-fiber composite comprising: a porous block having one or more pores; and a plurality of inorganic nano-fibers formed within at least one of the pores of the porous block. Also disclosed is the method for making a porous block and a filtering system for filtering out heavy metals and pathogens comprising a porous block. The preferred porous block is a carbon porous block and the nanofibers are preferably formed from at least one of: an aluminate, a titanate, and an inorganic oxide.
Patent NZ-623942-A (NZ)
Title: Building jacking system and method
Inventor: ALLAN JOHN CHAMBERS
IPC: E04G23/06
Filed: 2013-01-18
Abstract: System for lifting buildings (5) comprising two or more pairs of lifting units (2), and two or more modular trusses (3) which connect each pair of lifting units. Each pair of lifting units are placed either side of a building to be lifted. A truss is placed between each pair and attached to the building. The lifting units raise each truss and in turn lift the building. The lifting units are only placed on two opposing sides of the building. Each lifting unit comprises a hydraulic ram for raising and lowering the associated truss. Each truss may have no direct connection to the other truss(es). Each truss may be configured to attach to the internal or external walls of the building. The lifting unit may further comprise a foot, a lift end cap, two lift legs and a truss carrier. The hydraulic rams may further comprise a position sensor, and a control unit (4) may be further provided to control the extension of each hydraulic ram. The hydraulic ram may comprise two truss carrier connection points to allow for a two stage lift. A method of using the system is also provided.